Yuyu Pharma, Inc. (KRX:000220)
South Korea
· Delayed Price · Currency is KRW 4,555.00
+10.00 (0.22%)
Feb 21, 2025, 9:00 AM KST
Yuyu Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 73,712 | 85,445 | 102,750 | 130,082 | 108,199 | 66,725 | Upgrade
|
| Market Cap Growth | 1.63% | -16.84% | -21.01% | 20.22% | 62.16% | 8.45% | Upgrade
|
| Enterprise Value | 77,670 | 119,950 | 114,352 | 120,293 | 117,748 | 69,419 | Upgrade
|
| Last Close Price | 4555.00 | 5162.01 | 6081.01 | 7509.62 | 6924.50 | 5303.20 | Upgrade
|
| PE Ratio | 8.61 | - | - | - | 108.35 | 15.04 | Upgrade
|
| PS Ratio | 0.55 | 0.62 | 0.74 | 1.12 | 1.10 | 0.73 | Upgrade
|
| PB Ratio | 0.62 | 0.71 | 0.83 | 1.01 | 0.92 | 0.74 | Upgrade
|
| P/TBV Ratio | 0.64 | 0.81 | 0.93 | 1.11 | 0.99 | 0.78 | Upgrade
|
| P/FCF Ratio | 3.07 | - | - | - | - | 13.01 | Upgrade
|
| P/OCF Ratio | 2.59 | 203.02 | - | 28.85 | - | 5.06 | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.87 | 0.82 | 1.04 | 1.20 | 0.76 | Upgrade
|
| EV/EBITDA Ratio | 4.38 | 24.69 | 25.78 | 21.09 | 11.58 | 6.20 | Upgrade
|
| EV/EBIT Ratio | 6.42 | - | - | 100.23 | 18.78 | 8.60 | Upgrade
|
| EV/FCF Ratio | 3.24 | - | - | - | - | 13.53 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.33 | 0.32 | 0.30 | 0.17 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 1.95 | 8.11 | 8.86 | 6.87 | 1.96 | 2.41 | Upgrade
|
| Debt / FCF Ratio | 1.48 | - | - | - | - | 5.25 | Upgrade
|
| Asset Turnover | 0.68 | 0.70 | 0.72 | 0.66 | 0.67 | 0.67 | Upgrade
|
| Inventory Turnover | 1.96 | 2.11 | 2.64 | 2.89 | 2.60 | 2.72 | Upgrade
|
| Quick Ratio | 1.02 | 1.14 | 0.86 | 2.43 | 2.20 | 1.11 | Upgrade
|
| Current Ratio | 1.70 | 2.03 | 1.50 | 3.29 | 3.50 | 1.53 | Upgrade
|
| Return on Equity (ROE) | 8.21% | -4.55% | -3.51% | -0.75% | 2.32% | 6.27% | Upgrade
|
| Return on Assets (ROA) | 3.96% | -0.24% | -0.19% | 0.43% | 2.68% | 3.70% | Upgrade
|
| Return on Capital (ROIC) | 4.76% | -0.29% | -0.22% | 0.49% | 3.08% | 4.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.10% | - | - | 0.74% | 4.59% | 8.48% | Upgrade
|
| Earnings Yield | 11.61% | -8.40% | -5.83% | -1.70% | 1.19% | 7.08% | Upgrade
|
| FCF Yield | 32.57% | -4.79% | -11.20% | -1.20% | -13.60% | 7.69% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | 118.38% | 30.58% | Upgrade
|
| Buyback Yield / Dilution | -25.44% | 1.89% | -3.90% | -32.81% | 19.87% | -0.14% | Upgrade
|
| Total Shareholder Return | -25.44% | 1.89% | -3.90% | -32.81% | 19.87% | -0.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.